Nvidia-Backed Iambic Therapeutics Files for Nasdaq IPO as ‘IAM’
Iambic Therapeutics, backed by Nvidia and Qatar's sovereign fund, has filed for a Nasdaq IPO under ticker IAM to fund cancer drug trials.
Markets
Delayed ยท 08:04 UK
Topic
Every Financial News story tagged TAK, newest first.
Iambic Therapeutics, backed by Nvidia and Qatar's sovereign fund, has filed for a Nasdaq IPO under ticker IAM to fund cancer drug trials.